According to the latest studies, two doses of the Pfizer-BioNTech vaccine reduce the risk of hospitalization by 70% if infected with the "omicron" strain of the coronavirus, Reuters writes.
The study was conducted by the South African private insurance company Discovery Health. The researchers took the data from 211,000 people infected with the coronavirus between November 15 and December 7. About 78,000 of them were infected with the "Omicron" strain.
The results of the study showed that two doses of the Pfizer-BioNTech vaccine reduce the risk of omicron infection by 33%.
As for the booster dose, Report.ge wrote that three doses of Pfizer / BioNTech vaccine neutralize the new strain of coronavirus "Omicron."
According to recent studies, the experimental coronavirus pill developed by Pfizer reduces the risk of hospitalization or death by 89%.
The World Health Organization has named a new variant of the coronavirus found in South Africa "Omicron." "Omicron" is the 15th letter of the Greek alphabet (Ο).
